“One of the biggest barriers to care with KAP is actually not eligibility — it’s language. People can’t access a treatment that they don’t understand.”
When therapists integrate Ketamine-Assisted Psychotherapy (KAP) into their practice, a new clinical responsibility emerges: they need to be able to explain it clearly.
In many cases, therapists are the first point of contact for clients learning about KAP. Some clients may already be on the therapist’s caseload and could benefit from the treatment. Others may begin asking questions after hearing that the therapist offers KAP. Some may be referred specifically for this work by colleagues.
Regardless of how the conversation begins, therapists often find themselves introducing the model, answering initial questions, and helping clients decide whether KAP is something they want to explore further.
In a collaborative care model, education is shared across the care team. Therapists often help clients understand the structure of KAP and explore whether it fits their treatment goals. Prescribers then determine medical eligibility, discuss safety considerations, and oversee medication management.
Both roles are essential, but the therapist is frequently the first clinician helping the client make sense of what KAP is and how it works.
As Jay Karr explains, when each provider stays in their lane, trust increases — both for the client and across the care team.
This collaborative structure was a central theme in Journey Clinical’s recent clinician conversation on client education. The session featured two complementary perspectives that reflect how KAP is delivered in practice:
- Samantha Stroeh, PMHNP-BC, a Journey Clinical prescriber, speaking from the medical intake and safety-monitoring lens
- Jay Karr, LPCC, NCC, a KAP therapist and practice owner, speaking from the preparation, dosing support, and integration lens
What follows synthesizes Sam and Jay’s guidance on how therapists can talk with clients about KAP in a way that supports informed consent, preserves therapeutic integrity, and expands treatment options without overstepping.
Click here to watch the full presentation on our public Youtube channel:
Key Takeaways
- Lead with clarity: clients can’t consent to what they don’t understand.
- Describe the model, not just the medicine: preparation → dosing support → integration.
- Hold autonomy at the center: expand options without steering decisions.
- Slow down urgency: desperation is a clinical signal for pacing, not acceleration.
- Set expectations for variability: there is no single “right” subjective experience.
- Integration is a core safety feature, not an optional add-on.
1) Start With Clear Scope: What KAP Is and What It Isn’t
When introducing KAP to clients, Sam begins with straightforward psychoeducation. Many clients have heard about ketamine in very different contexts, so grounding the conversation in clear medical language helps establish a shared understanding.
“Ketamine is actually a dissociative anesthetic. It’s not a classic psychedelic, but it has psychedelic-like properties, which is why it falls under the umbrella of Psychedelic-Assisted Psychotherapy. It’s generally very safe when used appropriately. In this context, we’re using it as a clinical tool, a clinical treatment to treat a mental health disorder or symptoms and it always includes integration with a therapist.”
Starting with this type of explanation helps clients understand that KAP is not simply medication administration. It is a psychotherapy model that combines medical oversight, preparation, a supported dosing session, and integration work afterward.
For therapists, this framing also helps keep the conversation within scope. The therapist is not prescribing medication or making medical determinations, but they can explain how the treatment model works and help clients decide whether it might be worth exploring eligibility with a prescriber.
2) Describe the Full Container: Preparation, Dosing Support, and Integration
Jay was unequivocal on this point: KAP is not the medication alone. The treatment is the container — and the container includes preparation, collaborative care, and integration.
He returned repeatedly to the importance of stabilization before activation:
“Make sure that we stabilize before we catalyze… I think of a plane and the dual wings. One is the medical provider. The other wing is us as the psychotherapist. Ketamine is kind of like the fuel for the engine — that’s going to get you off the ground. Certainly, however, if you want to stay flying, it really takes that support… The integration then is not only flying that plane, but also being able to land that safely.”
In that analogy, ketamine is not the treatment in isolation — it is the catalytic element inside a larger system of care. The two wings — medical oversight and psychotherapy — create lift and stability. Without both, the model collapses.
Jay emphasized that preparation is not a formality. It is where stabilization, resourcing, expectation-setting, and therapeutic alliance are built. It is where you assess readiness, clarify intentions, and establish the client’s capacity to work with what may emerge.
Integration, in his framing, is not a debrief. It is where change consolidates.
He spoke directly to the reality that some clients are interested in the experience but less interested in the integration work. In those cases, discernment matters. In a psychotherapy-supported KAP model, integration is not optional — because the goal is not an acute state change. The goal is sustained behavioral and relational change.
When therapists explain KAP to clients, describing this full container matters. It sets realistic expectations, reinforces that psychotherapy remains central, and clarifies why collaborative care — therapist and prescriber in clear roles — is a strength rather than a complication.
If you are referencing Journey Clinical’s model in conversation, you can also direct clients to the published overview of appointment types and preparation expectations so that the structure is transparent before consent.
3) When a Client Asks, “Should I Do KAP?”: Expanding Options Without Taking the Wheel
One of the most common — and loaded — moments in a KAP conversation happens if a client asks:
“If you were me, would you do this?”
Jay was clear: this is not a question to answer directly. It’s clinical material.
“My stance is one of humility, of expanding the client’s options without steering their choice. I share that advice is cheap because I don’t have to live with the consequences of that. They’re the expert on their life.”
He then offered the restaurant analogy as a way of illustrating how to provide guidance without overriding autonomy:
“If you go to a restaurant and you ask the server, ‘What’s the best thing on the menu?’ they might say, ‘A lot of people really like this.’ That allows for freedom and agency.”
Instead of giving a yes-or-no answer, Jay reflects the question back into the client’s internal process:
- “What would it bring up if I said yes?”
- “What would it bring up if I said no?”
- “What answer are you most hoping to hear from me?”
Those questions surface fear, urgency, hope, ambivalence, and fantasy. In other words, the KAP conversation becomes a part of the therapy session.
This approach aligns directly with core psychotherapy ethics around informed consent and respect for autonomy. Clients cannot meaningfully consent if they feel subtly directed, reassured into compliance, or rescued from uncertainty. Expanding the “menu” of options while keeping decision-making with the client protects both the alliance and the integrity of the work.
And importantly, this stance does not make the therapist passive. You can:
- Clarify what KAP is.
- Describe who it may help.
- Name risks and limits.
- Share patterns you’ve observed.
What you don’t do is decide for them. When therapists learn how to hold this moment well, talking about KAP becomes a collaborative exploration of fit.
4) What Does It Feel Like? Preparing Clients Without Creating Expectations
“What does it feel like?” is one of the most common questions therapists hear when discussing Ketamine-Assisted Psychotherapy. Clients are often trying to orient themselves. They may have heard about ketamine through media, online forums, or friends. Some expect something psychedelic. Others worry about feeling out of control. Many simply want to know what they are agreeing to.
Sam approaches this through psychoeducation. She starts by clarifying what ketamine is in a clinical context and how it is being used in treatment.
“Ketamine is actually a dissociative anesthetic. It’s not a classic psychedelic, but it has psychedelic-like properties… In this context, we’re using it as a clinical tool… integrated with therapy.”
From there, the explanation shifts to what patients can generally expect during a dosing session within Journey Clinical’s model. Journey’s patient education materials describe it this way:
“The effects of ketamine, which most patients find pleasant, last for approximately 45 minutes. These effects can make you feel ‘far from’ your body and facilitate shifts in perception that can often feel expansive in nature. Many people report having unique emotional or visual experiences that can give you a break from habitual thoughts and gain a new perspective on traumatic situations. Your motor and verbal abilities will be reduced, so you’ll be lying down in a comfortable position during the experience. Once these effects subside, your psychotherapist will spend the remainder of your appointment giving you space to process and discuss your experience. While it may feel hard to articulate what happens during the experience, patients feel like the insights gained are clear.”
This type of description prepares clients for altered perception and temporary physical changes while reinforcing that the therapist remains present to support.
Sam also emphasizes variability. Not every client has the same subjective experience, and not every session looks the same.
“It tends to be different for everybody. For some people it can feel like you’re floating, for others, sinking, or hearing may feel heightened. Not everybody is going to have visuals. A visual experience does not mean this is or isn’t working. I also normalize somatic experiences, emotional release, and crying.”
Jay builds on this point from the therapist’s perspective:
“Even if you have your own personal experiences, that’s not going to dictate what their experience is going to be like. Even across sessions it can be wildly different. Ketamine is a little bit of a chameleon as far as that subjective experience. It’s about normalizing the possibilities more than saying, ‘It’s going to be like this.’”
The goal is not to script the experience or imply that certain sensations indicate success. The goal is to prepare clients to work with whatever emerges and to understand that the dosing session is one component of a broader therapeutic process.
When therapists handle this question with clear psychoeducation and realistic framing, clients tend to feel more oriented and less anxious. It also reinforces an important message: the experience itself matters, but the preparation and integration around it are what support lasting change.
5) Managing Expectations When Clients Feel Desperate
Many clients exploring KAP have already tried multiple treatments. It is common to hear statements like, “This feels like my last hope.”
Sam described this moment as one where pacing becomes especially important.
“I emphasize that KAP is not a magic pill. A lot of times what I’ll hear is the expectation that this is going to fix everything. My job is to slow things down and explore those expectations.”
Rather than shutting down hope, the goal is to help clients approach the treatment thoughtfully. This may include reviewing prior treatments, exploring what the client hopes will change, and clarifying what KAP can and cannot do.
Helping clients approach the treatment with realistic expectations supports informed consent and protects the therapeutic alliance.
6) Address Stigma and Safety Questions With Direct Language and Clinical Scaffolding
Many clients approach ketamine with mixed feelings. Some are curious, while others arrive with concerns shaped by cultural stigma, media coverage, or things they’ve heard from friends. Questions like “Isn’t this just getting high?” or “Isn’t ketamine a street drug?” are common.
Jay recommends meeting those concerns directly rather than avoiding them.
“Sometimes I lead with what clients have already heard. They might say, ‘Isn’t this just getting high?’ or ‘Isn’t this a street drug?’ I think of it as leading with the ugly — naming the concerns people already have and then shifting into the clinical context.”
From there, the conversation can move toward the factors that distinguish medical treatment from other forms of use: screening, dosing protocols, therapeutic support, and integration.
Jay also noted that language matters here as well. Rather than describing ketamine use as “recreational,” he prefers the phrase “non-prescribed use,” which more clearly distinguishes unsupervised use from treatment delivered in a clinical setting.
“It helps clients see the difference between a medication used in a therapeutic container and something taken outside of that context.”
These conversations can also be an opportunity to reinforce collaborative care. Therapists do not need to answer every medical question themselves. Instead, they can help clients identify concerns and bring those questions to the prescribing clinician.
In practice, this might sound like:
- “That’s a really important question to bring to the prescriber.”
- “Let’s write that down so you can ask about it during your medical consultation.”
Directing clients to patient education resources — such as Journey Clinical’s explanation of the KAP treatment model — can also help reinforce accurate information without requiring the therapist to carry the entire educational burden during a session.
Handled this way, stigma becomes an entry point for informed dialogue rather than a barrier to care.
7) “Will Things Get Worse Before It Gets Better?” The Role of Integration
Another concern that can arise in early conversations is whether psychedelic therapy modalities such as Ketamine-Assisted Psychotherapy (KAP) could make things feel worse before they improve.
Jay approaches this question through the lens of resourcing and integration. As therapy begins to illuminate difficult or previously unseen material, the experience can sometimes feel more intense in the short term. What matters most is whether the client has the support and resources to work with what emerges.
“When people ask whether things can get worse before they get better, I think about resources. What makes something traumatic isn’t just the event itself — it’s whether someone has the resources afterward to process it.”
This is one reason preparation and integration are central to the KAP model. Preparation helps establish safety and resourcing before the dosing session, while integration creates space to process insights, emotions, and newly surfaced parts of one’s experience afterward. What may initially feel unfamiliar or uncomfortable can, with support, become an opportunity to understand and integrate aspects of oneself that were previously harder to see.
Sam frames this conversation as part of informed consent, particularly for clients with trauma histories.
“I explain that difficult material can come up, and that doesn’t necessarily mean something is going wrong. That’s why the therapist’s support and the integration process are so important. And we can always slow the pace if needed.”
For many clients, hearing this framing reduces anxiety. It clarifies that emotional intensity is not a sign of failure, but something the therapeutic container is designed to support.
When therapists discuss this openly, they help clients approach KAP with a clearer understanding of the process and the supports that surround it.
Related Articles
- Doing KAP With Journey Clinical
- Preparation and Integration for Ketamine-Assisted Psychotherapy
- Understanding the Cost of Ketamine-Assisted Psychotherapy (KAP) at Journey Clinical
Client Education Resources
Frequently Asked Questions
How do I bring up KAP with a client?
You can introduce it the same way you would any treatment option: as one possible approach among many. A simple starting point is: “I want to make sure you’re aware of all of your options. One treatment model some clients explore is Ketamine-Assisted Psychotherapy.”
How do I explain Ketamine-Assisted Psychotherapy (KAP) briefly?
“Ketamine-Assisted Psychotherapy (KAP) is a structured therapy process that combines talk therapy with ketamine as an adjunct. The treatment includes medical oversight, preparation sessions, a dosing session with therapeutic support, and integration afterward. Together, these components help translate a temporary window of psychological flexibility into meaningful and lasting change.
In the Journey Clinical model, a licensed KAP provider supports the psychotherapy portion of treatment, while Journey Clinical’s medical team manages the medical aspects. This includes determining eligibility, developing a treatment plan, prescribing medication, and monitoring outcomes.
Ketamine has been used safely in medicine for decades and is now widely studied for mental health conditions including depression, anxiety, and PTSD, particularly when other treatments have not been effective.”
What should I say if a client asks how ketamine works?
“Ketamine works differently from most psychiatric medications. Rather than acting primarily on serotonin, it affects the neurotransmitter glutamate, which plays a role in learning and brain connectivity. This can temporarily increase neuroplasticity—the brain’s ability to form new connections—which may allow clients to approach thoughts, emotions, and memories from a different perspective during therapy.
The effects of ketamine during a dosing session typically last around 45 minutes. During this time, clients may experience shifts in perception or emotional insight. The client then processes the experience with the support of their therapist during dedicated integration sessions.”
I feel hesitant bringing up KAP with clients. Should I mention it?
Many therapists feel hesitant introducing a treatment that involves medication, especially if they are concerned about sounding directive or promotional.
However, clients rely on their therapists to help them understand the range of treatment options available. If you believe KAP could be relevant for a client, it is appropriate to introduce it as one option among others and invite discussion.
For example, you might say:
“I want to make sure you're aware of the different approaches available. One option some clients explore is Ketamine-Assisted Psychotherapy. If you're curious, we can talk about what that process looks like and whether it might be worth considering.”
This keeps the conversation collaborative while ensuring clients have access to accurate information.
Should I share my own KAP experience with clients?
Some therapists choose to disclose their own experience with KAP, and in certain contexts this can help build trust and reduce uncertainty for clients.
If you do share personal experience, it is helpful to emphasize that everyone’s experience is different. The goal is not to set expectations about what a client will feel, but to normalize the process and help them feel more comfortable asking questions.
A balanced approach might sound like:
“I have personal experience with this work, and it helped me understand the process more deeply. At the same time, everyone’s experience with ketamine is different, so we would focus on preparing you for whatever emerges.”
Keeping the focus on the client’s experience ensures the disclosure remains clinically appropriate.
What if a client asks me whether they should try KAP?
Rather than answering directly, explore the question together. Ask what they hope would change, what concerns they have, and what answer they are hoping to hear.
How do I stay within my scope when discussing KAP?
Therapists can explain the psychotherapy model, preparation, and integration. Medical eligibility, dosing, and safety questions should be directed to the prescribing clinician. Journey Clinical offers semiweekly Medical Q&A Office Hours for therapists to ask medical questions, and our medical team can support you in answering client questions.
What if a client is nervous about the experience itself?
Providing clear psychoeducation about what the dosing session may feel like — while emphasizing variability — helps clients feel more oriented and reduces anxiety. You can also have them try laying down and listen to music as part of a regular therapy session so that they can experience some of what the session will be like.
Are you a psychotherapist looking to integrate ketamine-assisted psychotherapy in your practice?